- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06956625
Cleansing Efficacy of Cosmetic Product (Cleanser)
June 17, 2025 updated by: Amazentis SA
Cleansing Efficacy of Cosmetic Products - Particular Matter Model
The aim of this study is to investigate the cleansing effect of one cosmetic product containing Mitopure against a particular matter model pollutant in comparison to an untreated control.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
24
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Schenefeld, Germany
- SGS proderm GmbH
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Written informed consent to participate in the study
- Willingness to actively participate in the study and to come to the scheduled visits
- Female and/or male
- From 18 to 70 years of age
- Healthy skin in the test area
- Skin type on Fitzpatrick scale: I, II or III
Exclusion Criteria:
- Female subjects: Pregnancy or lactation
- Drug addicts, alcoholics
- AIDS, HIV-positive or infectious hepatitis
- Conditions which exclude a participation or might influence the test reaction/evaluation
- Participation or being in the waiting period after participation in cosmetic and/or pharmaceutical studies pertaining to the test area
- Cancer not being diagnosed as cured and requiring chemotherapy, irradiation and/or hormonal treatment within the last 2 years
- Active skin disease at the test area
- Wounds, moles, tattoos, scars, irritated skin, excessive hair growth, etc. at the test area that could influence the investigation
- Any topical medication at the test area within the last 4 weeks prior to the start of the study and during the study
- Documented allergies to cosmetic products and/or ingredients
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Cosmetic product
Test area topically washed with cleanser containing Mitopure
|
After applying the model pollutant, the test area will be topically cleaned with the active cosmetic cleanser with Mitopure.
|
|
Other: Tap water (control)
Test area topically washed with tap water
|
After applying the model pollutant, the test area will be topically cleaned with tap water (control).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Luminosity (L)
Time Frame: Before pollutant application (t0), immediately after evaporation of the applied pollutant (t1), and 20 minutes after product rinse-off (t2)
|
Luminosity in test area assessed by HiRIS (High Resolution Imaging System) image analysis will be used to quantify cleaning efficacy.
|
Before pollutant application (t0), immediately after evaporation of the applied pollutant (t1), and 20 minutes after product rinse-off (t2)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Dr Katrin Unbereit, SGS proderm GmbH
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 8, 2025
Primary Completion (Actual)
May 9, 2025
Study Completion (Actual)
May 9, 2025
Study Registration Dates
First Submitted
April 23, 2025
First Submitted That Met QC Criteria
May 1, 2025
First Posted (Actual)
May 4, 2025
Study Record Updates
Last Update Posted (Actual)
June 18, 2025
Last Update Submitted That Met QC Criteria
June 17, 2025
Last Verified
June 1, 2025
More Information
Terms related to this study
Other Study ID Numbers
- 25.0054-60
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy Skin
-
Biocoz Global Pte. Ltd.Not yet recruitingHealthy Skin | Skin HydrationUnited States
-
University of California, San DiegoCompleted
-
Amazentis SARecruitingHealthy | Healthy Aging | Healthy DietUnited States
-
Amazentis SASGS proderm GmbHCompleted
-
Rao DermatologyRecruitingHealthy SkinUnited States
-
First Hospital of China Medical UniversityNot yet recruiting
-
Oslo University HospitalUniversity Hospital of North Norway; National Institute of Occupational Health...CompletedHealthy Skin | Sunburned Skin | Titanium Dioxide | Nanoparticles | Penetrate SkinNorway
-
AllerganCompletedHealthy Adults | Skin EnhancementPoland
-
University of MichiganCompletedHealthy Skin | Skin Wrinkling
Clinical Trials on Topical cosmetic cleanser
-
Medical University of WarsawCompletedTelogen Effluvium | Androgenetic Alopecia (AGA) | Female Pattern Hair Loss, Androgenic Alopecia
-
L'OrealCompletedVisible Light Exposure on Healthy Back SkinRomania
-
Johnson & Johnson Consumer Inc. (J&JCI)CompletedDermatitis, Atopic | Rosacea | Acne Vulgaris | Sensitive SkinUnited States
-
University of ManchesterUnknownPhotoagingUnited Kingdom
-
Dr. August Wolff GmbH & Co. KG ArzneimittelSIT Skin Investigation and Technology Hamburg GmbHCompleted
-
Dr. August Wolff GmbH & Co. KG ArzneimittelSIT Skin Investigation and Technology Hamburg GmbHCompleted
-
L'OrealCompletedVisible Light Exposure on Healthy Back SkinRomania
-
Johnson & Johnson Consumer Inc. (J&JCI)Completed
-
Johnson & Johnson Consumer Inc. (J&JCI)Completed
-
Cosmetique Active InternationalCompletedHealthy Volunteers | Hyperpigmentation | Skin PigmentationRomania